Native Pet Market Intelligence

Native Pet is a Manufacturer in the Pharmaceutical Manufacturing industry. It develops, sources, and produces medicinal and therapeutic products — covering prescription drugs, OTC formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. The company serves pharmaceutical brands, healthcare providers, hospital networks, and regulated distribution channels.

Native Pet was founded in 2017. That history reflects deeper regulatory expertise, more validated manufacturing processes, and stronger relationships with approved API suppliers and healthcare buyers.

Native Pet is headquartered in United States. Location directly affects regulatory jurisdiction — US-based manufacturers operate under FDA oversight, while companies in other regions follow EMA, WHO-GMP, or local health authority frameworks.

Native Pet operates as a Manufacturer. Manufacturers develop and produce pharmaceutical formulations; CDMOs provide contract development and manufacturing for third-party brands; API suppliers deliver raw active ingredients to formulators. Native Pet may operate across more than one of these roles.

Visit nexusplatform.ai/company/details/nativepet.com for the full profile — company type, key contacts, product range, therapeutic areas, and certifications, all in one place.

Native Pet is led by Bobbie Rogers, Co-Manufacturing Manager. Leadership in pharmaceutical manufacturing typically comes from medicinal chemistry, regulatory affairs, clinical development, or operations — backgrounds that directly shape product safety, compliance, and pipeline strategy.